NCT04925154 Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.
| NCT ID | NCT04925154 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital |
| Condition | Patient Preference |
| Study Type | OBSERVATIONAL |
| Enrollment | 192 participants |
| Start Date | 2021-12-13 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 192 participants in total. It began in 2021-12-13 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.
Eligibility Criteria
Inclusion Criteria: Group A * New rectal cancer patient * Operable patients * Capable adults older than 18 years of age * Capacity to sign a consent form * Capacity to answer questionnaires on an online platform Group B * Treating physician specialists * Capacity to sign a consent form * Capacity to answer questionnaires on an online platform Exclusion Criteria: Group A: * Patient unable to sign a consent form * Patients with metastasis * Recurrent tumours * Inability to answer questionnaires on an online platform * Inability to communicate in french or english Group B: * Participant unable to sign a consent form * Inability to answer questionnaires on an online platform
Contact & Investigator
Té Vuong
PRINCIPAL INVESTIGATOR
Lady Davis Institute - JGH
Frequently Asked Questions
Who can join the NCT04925154 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patient Preference. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04925154 currently recruiting?
Yes, NCT04925154 is actively recruiting participants. Contact the research team at emma.starr.ccomtl@ssss.gouv.qc.ca for enrollment information.
Where is the NCT04925154 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT04925154 clinical trial?
NCT04925154 is sponsored by Sir Mortimer B. Davis - Jewish General Hospital. The principal investigator is Té Vuong at Lady Davis Institute - JGH. The trial plans to enroll 192 participants.